Regulation of complement C3 synthesis by interleukin-1 and transforming growth factor-beta in rat non-transformed intestinal epithelial cell line, IEC-6

被引:8
作者
Andoh, A [1 ]
Fujiyama, Y [1 ]
Hata, K [1 ]
Sumiyoshi, K [1 ]
Bamba, T [1 ]
机构
[1] SHIGA UNIV MED SCI,DEPT INTERNAL MED,OTSU,SHIGA 52021,JAPAN
关键词
cytokine; IL-1; beta; TGF-beta; complement; epithelial cell; cell line IEC-6;
D O I
10.1007/BF02347609
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Intestinal epithelial cells are an important source of many biologically active molecules that modulate immune responses in the mucosa. The purpose of this study was to demonstrate the synthesis of complement C3 component in the rat non-transformed crypt-like intestinal epithelial cell line, IEC-6. Unstimulated IEC-6 cells secreted a low level of C3 protein and showed weak expression of C3 mRNA. The addition of interleukin (IL)-1 beta induced a dose- and time-dependent increase in C3 production. These effects of IL-1 beta were observed at a concentration as low as 0.01 ng/ml and reached a plateau at a concentration of 5 ng/ml. The effects were observed at the mRNA level as early as 6 h after the beginning of incubation. Transforming growth factor (TGF)-beta alone had no effect. However, TGF-beta at low concentrations (0.001-1 ng/ml) enhanced the effect of IL-1 beta in increasing C3 production; this enhancement was not observed at high concentrations (5-10 ng/ml). These effects of TGF-beta were also observed at the mRNA level. The present findings indicate that intestinal epithelial cells are indeed capable of synthesizing complement C3 in response to IL-1 beta and TGF-beta.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 37 条
[1]   ENHANCED LOCAL PRODUCTION OF COMPLEMENT COMPONENTS IN THE SMALL-INTESTINES OF PATIENTS WITH CROHNS-DISEASE [J].
AHRENSTEDT, O ;
KNUTSON, L ;
NILSSON, B ;
NILSSONEKDAHL, K ;
ODLIND, B ;
HALLGREN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (19) :1345-1349
[2]   FLOW CYTOMETRIC ASSAY FOR PHAGOCYTOSIS OF HUMAN MONOCYTES MEDIATED VIA FC-GAMMA-RECEPTORS AND COMPLEMENT RECEPTOR CR-1 (CD35) [J].
ANDOH, A ;
FUJIYAMA, Y ;
KITOH, K ;
HODOHARA, K ;
BAMBA, T ;
HOSODA, S .
CYTOMETRY, 1991, 12 (07) :677-686
[3]  
ANDOH A, 1993, J IMMUNOL, V151, P4239
[4]  
Andoh A., 1995, Pathophysiology, V2, P251, DOI DOI 10.1016/0928-4680(95)00033-2
[5]  
ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
[6]   EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES [J].
ASSOIAN, RK ;
FLEURDELYS, BE ;
STEVENSON, HC ;
MILLER, PJ ;
MADTES, DK ;
RAINES, EW ;
ROSS, R ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6020-6024
[7]   REGULATION OF INTESTINAL EPITHELIAL-CELL GROWTH BY TRANSFORMING GROWTH-FACTOR TYPE-BETA [J].
BARNARD, JA ;
BEAUCHAMP, RD ;
COFFEY, RJ ;
MOSES, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1578-1582
[8]  
BARNUM SR, 1994, J IMMUNOL, V152, P765
[9]  
BROOIMANS RA, 1990, J IMMUNOL, V144, P3835
[10]  
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434